Certain biomarkers are created for the purpose of providing detail the dangers of cardiovascular disease. However, the clinical value of these biomarkers is debatable. Today getting biomarkers reflect a greater conflict of cardiovascular disease include:
a. Increased blood concentrations of fibrinogen and PAI-1.
b. Elevated homocysteine Blevel or even more than half
c. Elevated blood levels of asymmetrical dimethyl arginine.
d. Inflammation measured by elevated C-reactive protein.
e. Elevated blood levels of brain natriuretic peptide (also known as type-B) (BNP).
Fuente: Cardiovascular disease
a. Increased blood concentrations of fibrinogen and PAI-1.
b. Elevated homocysteine Blevel or even more than half
c. Elevated blood levels of asymmetrical dimethyl arginine.
d. Inflammation measured by elevated C-reactive protein.
e. Elevated blood levels of brain natriuretic peptide (also known as type-B) (BNP).
Fuente: Cardiovascular disease
No hay comentarios:
Publicar un comentario